Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia

Abstract

intravenous polymyxin B therapy was inferior to other drugs in the treatment of P. aeruginosa bacteraemia, as indicated by the higher rate of in-hospital mortality.